Who is sponsoring NCT05038267?

NCT05038267 is sponsored by Montreal Heart Institute.

What condition does NCT05038267 study?

NCT05038267 studies Heart; Dysfunction Postoperative, Cardiac Surgery, Right Heart Failure, Right Ventricular Dysfunction.

Is NCT05038267 still recruiting?

NCT05038267 is currently completed. Last updated 19 March 2024.

Last reviewed 2024-03-19 · How we verify

NCT05038267: FemousTechno6

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Femoral Venous Pulsatility and Right Heart Dysfunction in Heart Surgery: An Observational Study

Completed Last updated 19 March 2024

What this trial tests

trial in Heart; Dysfunction Postoperative, Cardiac Surgery in 150 participants. Completed in 30 August 2023.

Timeline

30 August 2021

Primary endpoint
30 August 2023

30 August 2023

Quick facts

Lead sponsor	Montreal Heart Institute
Status	Completed
Study type	OBSERVATIONAL
Enrollment	150
Start date	30 August 2021
Primary completion	30 August 2023
Estimated completion	30 August 2023
Sites	1 location across Canada

Conditions studied

Heart; Dysfunction Postoperative, Cardiac Surgery — all drugs for Heart; Dysfunction Postoperative, Cardiac Surgery →
Right Heart Failure — all drugs for Right Heart Failure →
Right Ventricular Dysfunction — all drugs for Right Ventricular Dysfunction →

Sponsor

Montreal Heart Institute

Who can join

18 and older, any sex, with Heart; Dysfunction Postoperative, Cardiac Surgery or Right Heart Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Right heart failure during cardiac surgery is associated with increased perioperative morbidity and mortality. In this context, it is imperative to develop simple diagnostic tools to detect right heart failure. The purpose of this observational study is to determine if ultrasound Doppler of the femoral vein can detect and predict right ventricular failure after cardiac surgeries requiring cardiopulmonary bypass. It is expected that an elevated pulsatility of the femoral vein before the induction of general anesthesia is associated with perioperative right heart failure.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Prevalence of abnormal common femoral vein pulsatility on Doppler ultrasound in patients undergoing cardiac surgery and its association with adverse events: a prospective cohort study.
Huard K, Lachance O, Parent M, Tawil P, et al · · 2025 · cited 2× · PMID 40032766 · DOI 10.1007/s12630-025-02911-9
Femoral Vein Pulsatility and Neurocognitive Disorder in Cardiac Surgery.
Hammoud A, Mailhot T, Parent M, Huard K, et al · · 2025 · cited 1× · PMID 40060204 · DOI 10.1016/j.cjco.2024.11.002

Verify or expand the search:

Other Montreal Heart Institute trials

Trials by the same sponsor.

NCT07524335 — Aspirin in Subclinical Coronary Artery Disease: A Pilot Randomised Controlled Trial · Phase 3 · not yet recruiting
NCT07257198 — Aspirin-free Strategy With Ticagrelor in Patients With a Myocardial Infarction Treated Medically Alone · Phase 3 · recruiting
NCT07391358 — DAPT Strategy in HBR Patients Undergoing Complex PCI Following ACS: Second-Phase Beta Testing of a Patients Decision Aid · NA · not yet recruiting
NCT05450328 — Inhaled Milrinone and Epoprostenol for the Prevention of Difficult Cardiac Pulmonary Bypass Separation · Phase 2 · not yet recruiting
NCT07144722 — Prehabilitation Program for Patients Awaiting Elective Heart Surgery at Increased Risk of Postoperative Complications: F · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05038267 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Montreal Heart Institute
Last refreshed: 19 March 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05038267.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing